Purpose To compare the vision-specific and cancer-specific quality of life (QOL) between
patients with and without ocular graft-versus-host disease (oGVHD) after allogeneic …

Purpose: To determine the influence of ocular complications on quality of life (QoL) 3 years
after allogeneic stem cell transplantation (allo‐SCT). Methods: All 54 adult patients that …

AIM To explore the relationship between ocular and systemic conditions and the impact of
ocular complications on the quality of life (QOL) in patients after allogeneic hematopoietic …

Purpose To assess the vision-related quality of life (QOL) in a cohort of patients with ocular
graft-versus-host disease (GVHD). Design Prospective study. Participants Eighty-four …

Purpose This study aimed to assess the prevalence and clinical manifestations of ocular
graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation …

Abstract Ocular GvHD affects about 40–60% of patients receiving bone marrow
transplantation. Ocular complaints worsen quality of life (QoL), which, besides survival time …

Ocular chronic graft-versus-host disease (cGVHD) has been shown to significantly reduce
quality of life after allogeneic hematopoietic stem cell transplantation (HSCT). To learn more …

Objectives: To investigate the sleep quality in patients with ocular graft-versus-host disease
(oGVHD) compared with patients without oGVHD after allogeneic hematopoietic stem cell …

In the past few decades, allogeneic hematopoietic stem cell transplantation (allo-HSCT) has
become successful in treating a variety of hematologic disorders, both benign and …

Objective: To study the factors affecting the time to onset of ocular graft-versus-host disease
(GVHD) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo …